We began 2012 with ambitious objectives to significantly grow our company’s top and bottom line as we march towards our overall objective of being the #1 specialty pharmaceutical company in the world.
We began 2012 with ambitious objectives to significantly growour company’s top and bottom line as we march towards our overallobjective of being the #1 specialty pharmaceutical company inthe world.